Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

By P. Mehta, K. Griendling. American Journal of Physiology - Cell Physiology, 2007

1,953 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/43b14811240904f4542dbecf3f4aec7c4b860b91

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. M. Grant
2. J. Zhong
3. Vaibhav B. Patel
4. G. Oudit
5. S. Dikalov

In Endocrinology, Diabetes and Metabolism

1. M. Grant
2. J. Zhong
3. Vaibhav B. Patel
4. G. Oudit
5. S. Dikalov

In Molecular Biology

1. M. Grant
2. J. Zhong
3. Vaibhav B. Patel
4. G. Oudit
5. S. Dikalov

Citations in the corpus

• Crosstalk between mitochondria and NADPH oxidases (2011, background): “Activation of NADPH oxidases is an early response of endothelial cells to AngII [114].”
• Renin‐angiotensin system revisited (2008, background): “We decided not to enter the complex field of intracellular AT1 and AT2 receptor signalling and therefore refer the reader to recent reviews [11, 12] .”
• Role of the ACE2/Angiotensin 1–7 axis of the Renin-Angiotensin System in Heart Failure (2016, positive): “In this review, we highlight the role of ACE2/Ang 1–7 in counter-regulation of Ang II actions, different approaches to manipulating ACE2/Ang 1–7 levels, and the potential of enhancing ACE2 action as a therapy for HF.”
• The pivotal link between ACE2 deficiency and SARS-CoV-2 infection (2020, neutral): “[40, 41] 4.3.”